What we do, and why.
TRIMT‘s Pipeline is widely orthogonal to mainstream research, granting leadership in our market sector.
The global market for radio-theranostics is expected to grow substantially.
TRIMT is committed to driving innovation and advancement in theranostics with a combination of unique technologies.
The global market for radio-theranostics is expected to grow substantially.
TRIMT is committed to driving innovation and advancement in theranostics with a combination of unique technologies.
CompoundTarget, ApplicationPreclinicalTranslationClinical
Trivehexin
αvβ6 Integrin, Dx (PET)
Therahexin
αvβ6 Integrin, Tx (RLT)
Technehexin
αvβ6 Integrin, Dx (SPECT)
Triveoctin
αvβ8 Integrin, Dx (PET)
LPDL1
PD-L1, Dx (PET)
Undisclosed
αvβ6 Integrin, Dx (PET)









